- Home
- EVAX vs PLAG Comparison
EVAX vs PLAG Comparison
Compare EVAX & PLAG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVAX
- PLAG
- Stock Information
- Founded
- EVAX 2008
- PLAG 1986
- Country
- EVAX Denmark
- PLAG United States
- Employees
- EVAX N/A
- PLAG N/A
- Industry
- EVAX Biotechnology: Biological Products (No Diagnostic Substances)
- PLAG Packaged Foods
- Sector
- EVAX Health Care
- PLAG Consumer Staples
- Exchange
- EVAX Nasdaq
- PLAG Nasdaq
- Market Cap
- EVAX 16.3M
- PLAG 18.9M
- IPO Year
- EVAX 2021
- PLAG N/A
- Fundamental
- Price
- EVAX $2.53
- PLAG $2.27
- Analyst Decision
- EVAX Strong Buy
- PLAG
- Analyst Count
- EVAX 3
- PLAG 0
- Target Price
- EVAX $33.33
- PLAG N/A
- AVG Volume (30 Days)
- EVAX 6.8M
- PLAG 5.7K
- Earning Date
- EVAX 03-26-2025
- PLAG 03-31-2025
- Dividend Yield
- EVAX N/A
- PLAG N/A
- EPS Growth
- EVAX N/A
- PLAG N/A
- EPS
- EVAX N/A
- PLAG N/A
- Revenue
- EVAX $3,295,000.00
- PLAG $16,965,260.00
- Revenue This Year
- EVAX $9,039.73
- PLAG N/A
- Revenue Next Year
- EVAX $1.47
- PLAG N/A
- P/E Ratio
- EVAX N/A
- PLAG N/A
- Revenue Growth
- EVAX N/A
- PLAG N/A
- 52 Week Low
- EVAX $2.22
- PLAG $1.18
- 52 Week High
- EVAX $22.05
- PLAG $5.52
- Technical
- Relative Strength Index (RSI)
- EVAX 40.91
- PLAG 44.18
- Support Level
- EVAX $2.43
- PLAG $2.24
- Resistance Level
- EVAX $2.80
- PLAG $2.47
- Average True Range (ATR)
- EVAX 0.31
- PLAG 0.17
- MACD
- EVAX 0.07
- PLAG -0.02
- Stochastic Oscillator
- EVAX 16.94
- PLAG 10.98
About EVAX Evaxion Biotech
Evaxion Biotech AS is a clinical-stage biotech company that aspires to the exploration of artificial intelligence, or AI, to develop immunotherapies with improved efficacy when compared to currently marketed products for patients with unmet medical needs. Its pipeline programs are derived from its proprietary AI platforms, PIONEER, EDEN, RAVEN, and ObsERV. The company is utilizing these AI platforms to build a drug development pipeline. Its product candidates are; EVX-01 and EVX-02, for the treatment of various cancers, and the third candidate is cancer immunotherapy, EVX-03, for the treatment of various cancers including non-small-cell-lung-cancer, or NSCLC, is in pre-clinical development.
About PLAG Planet Green Holdings Corp.
Planet Green Holdings Corp is a diversified technology and consumer products company with a presence in North America and China engaged in Chemical Products, Tea Products, and Online Advertising Services. The company operates in three segments namely to grow, produce, and distribute Cyan brick tea, black tea, and green tea in China; to research, develop, manufacture, and sell chemical products including formaldehyde, urea formaldehyde adhesive, methylal, ethanol fuel, fuel additives and clean fuel in China; and to develop and operate a demand-side platform which empowers buyers of advertising to manage and optimize their digital advertising across different real-time bidding networks in North America and China.